Surplus Solutions Expands Global Offerings with Refurbished

Endpoints NewsFDA Commissioner Makary to resign, source says

Endpoints NewsIran war disruptions begin to emerge upstream of the pharma supply chain

FierceBiotechCharles River debuts AI diagnostic tool to cut down pathology timelines

10x Genomics NewsThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - The Motley Fool

Endpoints NewsWhat I learned at a journalism fellowship about covering healthcare AI

BioPharma DiveArvinas, Pfizer find new partner for ‘Protac’ breast cancer drug

FierceBiotechAlphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

Endpoints NewsFive burning Qs for Isomorphic Labs after $2.1B raise for AI biotech

Lonza NewsLonza Launches Xcite AAV Producer Cell Line Platform - Contract Pharma

Endpoints NewsPfizer and Arvinas give disappointing breast cancer drug to Rigel

FierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

Endpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO says